Skip to main content

2 Result(s)

within Kazuo Jouyama Remove this filter

and

  1. No Access

    Article

    Comparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases

    Anti-cytokine therapy is reportedly useful in amyloid A (AA) amyloidosis complicating rheumatic diseases. However, to date no studies have directly compared the utility of tumour necrosis factor (TNF) inhibiti...

    Yasuaki Okuda, Makoto Ohnishi, Kenichiro Matoba, Kazuo Jouyama… in Modern Rheumatology (2013)

  2. No Access

    Article

    Successful tocilizumab treatment in a patient with adult-onset Still’s disease complicated by chronic active hepatitis B and amyloid A amyloidosis

    We report successful tocilizumab (TCZ) use in a patient with adult-onset Still’s disease (AOSD) complicated by chronic hepatitis B (CHB) and AA amyloidosis (AAA). Treatments with corticosteroid and various typ...

    Dai Kishida, Yasuaki Okuda, Makoto Onishi, Masashi Takebayashi… in Modern Rheumatology (2011)